Armel Poda
-
- Antibiotic Use and Resistance 8
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 7
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 18
- HIV/AIDS drug development and treatment 10
- COVID-19 Clinical Research Studies 6
- Endocrinology top 10%
- Geriatrics and Gerontology top 10%
-
- HIV, Drug Use, Sexual Risk 9
-
- HIV-related health complications and treatments 8
-
- Global Maternal and Child Health 7
- Co-authors
- Abdoul–Salam OuédraogoSylvain GodreuilFrançois-Xavier LescureRaheelah AhmadAnne PerozzielloGabriel BirgandHélène Jean‐PierreEsmita Charani
- Journals
- PLoS ONE (3 papers)International Journal of Cancer (1 paper)Frontiers in Microbiology (1 paper)
- Partner nations
- Burkina FasoFranceUnited States
In The Last Decade
Armel Poda
56 papers receiving 576 citations
Peers
Comparison fields: 5 of 78
- Applied Microbiology and Biotechnology 177
- Molecular Medicine 145
- Infectious Diseases 246
- Endocrinology 59
- Geriatrics and Gerontology 41
Countries citing papers authored by Armel Poda
This map shows the geographic impact of Armel Poda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armel Poda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armel Poda more than expected).
Fields of papers citing papers by Armel Poda
This network shows the impact of papers produced by Armel Poda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armel Poda. The network helps show where Armel Poda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Armel Poda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 3 | |
| 9 | COVID-19 Outbreak in Burkina Faso: EpidemiologicalSurveillance among High Risk Population | 2021 | 2 |
| 10 | 2021 | 3 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 28 | |
| 14 | 2018 | 85 | |
| 15 | 2016 | 28 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 5 | |
| 18 | 2016 | 20 | |
| 19 | 2011 | 1 | |
| 20 | The point on juvenile tetanus in the Clinic of Infectious Diseases of Fann Teaching Hospital, Dakar. | 2010 | 1 |
About Armel Poda
Armel Poda is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 64 papers that have together received 583 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (18 papers), HIV/AIDS drug development and treatment (10 papers), HIV, Drug Use, Sexual Risk (9 papers), HIV-related health complications and treatments (8 papers), Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (7 papers), Global Maternal and Child Health (7 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (177 citations), Molecular Medicine (145 citations) and Infectious Diseases (246 citations). Armel Poda has collaborated with scholars based in Burkina Faso, France and United States. Frequent co-authors include Abdoul–Salam Ouédraogo, Sylvain Godreuil, François-Xavier Lescure, Raheelah Ahmad, Anne Perozziello, Gabriel Birgand, Hélène Jean‐Pierre, Esmita Charani, Brita Skodvin and Nongodo Firmin Kaboré. Their work appears in journals such as PLoS ONE, International Journal of Cancer and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.